CVR 25550773Private limited company (ApS)Sundhedsvæsen i øvrigt i.a.n. (869090)Peter Kaads Vej 1, 6400 SønderborgFounded 11 Aug 2000
Compare withsimilar companiesanother companyits industry
Total Terapi ApS
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: Total Terapi ApS, https://dandex.ai/company/25550773/total-terapi. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about Total Terapi ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
1
CVR, 2022
Gross profit
76.8K
DKK, annual report 2022
-79.7% on 2021
Result
-202.4K
DKK, annual report 2022
Equity
385.9K
DKK, annual report 2022
John Ottesen100% of capital and votes, until 9 Sep 2024
John Ottesenuntil 15 Feb 2024
No current owner is registered.
100% of capital and votes11 Aug 2000 to 9 Sep 2024
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Oct 2022, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Aug 2022 | Sep 2022 | Oct 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 3 | 2 | No count | No count | No count | No count | 4 | 5 | 3 | 4 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 2 | 3 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 4 | 2 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 3 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Oct 2022, published 21 Dec 2022.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2022, DKK: Gross profit 76.8K, Operating profit -195.3K, Result for the year -202.4K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2022, DKK: Total assets 512.7K, Equity 385.9K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Gross profit | 563 | 537 | 505 | 379 | 77 |
| Operating profit | +13 | +31 | +345 | +265 | -195 |
| Result for the year | -43 | -27 | +103 | +206 | -202 |
| Equity | 306 | 279 | 382 | 588 | 386 |
| Total assets | 1,992 | 1,954 | 527 | 715 | 513 |
| Employees (average) | 1 | 1 | 1 | 1 | Not reported |
Annual report 2022
1 Jul 2021 to 30 Jun 2022, published 23 Dec 2022
Annual report 2021
1 Jul 2020 to 30 Jun 2021, published 15 Dec 2021
Annual report 2020
1 Jul 2019 to 30 Jun 2020, published 18 Dec 2020
Annual report 2019
1 Jul 2018 to 30 Jun 2019, published 2 Jan 2020
Annual report 2018
1 Jul 2017 to 30 Jun 2018, published 21 Dec 2018
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| DecreasePaid out to the owners, DKK 45,000 | None | None | None | 80,000 | |
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | -32.1% | -4.5% | -6.1% | -23.3% | -79.7% |
| EBITDA | 34 | 51 | 372 | 347 | -195 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | 0% | 0% | 0% | 0% | Not reportednote 1 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 1note 2 | 1note 2 | Not reportednote 3 | 207note 2 | 0note 2 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 22 Nov 2026.
17 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Skifteretsbehandlingen sluttet, virksomheden er opløst
Likvidatorer:
Fratrådte:
Søren Nygaard, den 09.09.2024.
Likvidatorer:
Tiltrådte:
Skifteretten i Sønderborg har udnævnt følgende likvidatorer: Søren Nygaard, 6400 Sønderborg, den 24.04.2024.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Skifteretten i Sønderborg den 15.02.2024
Direktion:
Fratrådte:
John Ottesen, den 15.02.2024.
Vedtægter ændret: 27.10.2022
Nyt navn: Total Terapi ApS
Ny adresse: Peter Kaads Vej 1, Vollerup, 6400 Sønderborg
Vedtægter ændret: 30.09.2016
Revision:
Fratrådte:
REVISION- OG REGNSKABSKONTORET ApS REGISTREREDE REVISORER, den 30.09.2016.
Ny adresse:
Ørstedsgade 44, 6400 Sønderborg.
Vedtægter ændret:
06.06.2011.
Kapitalnedsættelse besluttet 20.04.2011 er gennemført 06.06.2011.
Kapitalen udgør herefter kr. 80.000,00.
Kapitalnedsættelse besluttet 20.04.2011 udbetaling til anpartshavere kr. 45.000,00 til kurs 100,00.
Selskabets kreditorer opfordres til at anmelde deres krav til selskabet. Kreditorerne kan kræve betryggende sikkerhed for uforfaldne krav og betaling af forfaldne krav. Krav skal anmeldes senest 4 uger fra dags dato.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Revision:
Udtrådt af revisionen:
Revision- og Regnskabskontoret v/Henning Kjær, den 15.11.2005.
Indtrådt i revisionen:
CVR-NR. 28902867 REVISION- OG REGNSKABSKONTORET ApS, Østergade 10, 1., postboks 243, 6400 Sønderborg, den 15.11.2005.
Direktion:
Udtrådt af direktionen:
Jens Bremer Sørensen, den 01.06.2005.
Indtrådt i direktionen:
Direktør John Ottesen, den 01.06.2005.
Revision:
Udtrådt af revisionen:
CVR-NR. 10484286 VENDELBO INVEST ApS, den 21.11.2003.
Indtrådt i revisionen:
Revision- og Regnskabskontoret v/Henning Kjær, den 21.11.2003.
Revision:
Udtrådt af revisionen:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB.
Indtrådt i revisionen:
REVISION- OG REGNSKABSKONTORET SØNDERBORG ApS, Østergade 10, 1., 6400 Sønderborg.
Nyt navn:
ALSSUND & RASK ApS.
Ny adresse:
Grundtvigs Alle 170, 6400 Sønderborg.
Stiftelsesdato:
11.08.2000.
Seneste vedtægtsdato:
11.08.2000.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 100,00.
Stifter:
Jens Bremer Sørensen, den 11.08.2000.
Direktion:
Jens Bremer Sørensen, den 11.08.2000.
Selskabet tegnes af direktionen.
Revision:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Østergade 13, 8450 Hammel, den 11.08.2000.
Første regnskabsår:
10.08.2000 - 30.06.2001.
Regnskabsår:
01.07 - 30.06.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for Total Terapi ApS:
Have Pro? Sign in.
P-number 1007834973Torvet 8, 6400 Sønderborg
P-number 1008374461Peter Kaads Vej 1, 6400 Sønderborg